Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A

As of June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A carries a market capitalization of 25.72B, placing it among publicly traded companies globally. Its enterprise value stands at 24.49B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A's next confirmed earnings release is scheduled for April 26, 2027.

As of June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A has 1.00B shares outstanding.

As of June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 17.81. The price-to-sales ratio is 3.12, and the price-to-book ratio stands at 1.93.

As of June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A trades at an EV/EBITDA multiple of 15.08 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.99 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.08 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 24.49B versus a market cap of 25.72B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A maintains a current ratio of 2.76, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A posted a return on equity (ROE) of 10.87, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.62 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.62, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.70, useful for judging operating efficiency across full business cycles. The company generates approximately 1.05M in revenue per employee across its workforce of 7,807.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.26 indicates how many times Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A recorded 179.57M in income tax expense. That works out to an effective tax rate of 11.07, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.62B, leaving 1.44B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A's stock has declined approximately 26.09% over the past 52 weeks. The 50-day moving average sits at 26.12, while the 200-day moving average is 30.85.

Over the twelve months ended June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A generated 8.20B in revenue and converted that into 1.44B in net income, yielding earnings per share of 1.45. EBITDA reached 1.62B, while operating income came in at 1.45B.

As of June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A holds 1.38B in cash and equivalents against 26.48M in total debt, resulting in a net debt position of -1.38B. Total book value stands at 13.33B, with working capital of 5.57B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A posted a gross margin of 50.31, reflecting its pricing power and cost economics. The operating margin of 17.72 and net profit margin of 17.51 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A paid dividends of 0.40 per share. The dividend payout ratio of 27.58 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 6.04, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A shareholders.

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A's most recent stock split took place on May 26, 2017 with a 2:3 split ratio.

As of June 30, 2026, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Class A has an Altman Z-Score of 6.66, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.